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Abstract
Purpose: To investigate the association between 25-hydroxyvitamin D and diabetic
retinopathy (DR).
Methods: A population-based cross-sectional study using a nation-wide,
systemically stratified, multistage, clustered sampling method included a total of
18,363 subjects aged $40 years who participated in the Korean National Health
and Nutrition Examination Survey during 2008–2012. All participants participated in
standardized interviews, blood 25-hydroxyvitamin D level evaluations, and
comprehensive ophthalmic examinations. Seven standard retinal fundus
photographs were obtained from both eyes after pupil dilatation. DR was graded
according to the modified Airlie House classification system.
Results: The blood 25-hydroxyvitamin D levels were 19.2 ng/mL in men and
17.9 ng/mL in women. After adjusting for potential confounders, including age, sex,
diabetes duration, hemoglobin A1c levels, and hypertension, the odds ratios (OR)
for any DR and proliferative DR among men decreased significantly in the highest
blood 25-hydroxyvitamin D level quintile relative to the lowest quintile (OR, 0.37;
95% confidence interval [CI], 0.18–0.76; P for trend 50.004 and OR, 0.15; 95% CI,
0.03–0.83; P for trend 50.043).
Conclusions: This study provides the first epidemiologic findings of the inverse
relationships of blood 25-hydroxyvitamin D levels with any DR and proliferative DR
only in men. Considering anti-angiogenic and anti-fibrotic action of vitamin D,
further studies including longitudinal and interventional analysis are warranted.
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Diabetic retinopathy (DR), which is among the most common diabetes
complications, is a leading cause of blindness among working-aged adults
worldwide [1]. Major risk factors for DR include a longer diabetes duration, poor
glycemic control, and hypertension, which have been strongly and consistently
associated with DR across populations [2]. We previously reported that these 3
major risk factors could be applied to a representative Korean population, which
is same data of the present study [3]. Other potential risk factors, including
cardiovascular disease, lipid profiles, and obesity, have been inconsistently
associated with DR across populations [4,5]. Recently, an animal study found that
the active metabolite of vitamin D, calcitriol, was a potent inhibitor of retinal
neovascularization in an oxygen-induced ischemic retinopathy mouse model,
suggesting that vitamin D may protect diabetic retinas [6]. Moreover, vitamin D
has been implicated in the pathogenesis of type 2 diabetes mellitus [7]. Vitamin D
deficiency has been shown to affect insulin synthesis and secretion in both human
and animal studies [7].
Vitamin D, a circulating steroid hormone, has anti-angiogenic [6,8], anti-
inflammatory [9,10], and anti-fibrotic properties [11,12]. A number of studies
have demonstrated the anti-inflammatory function of vitamin D in vitro and vivo
[13–15]. Several human studies have shown inverse relationships between vitamin
D levels and several chronic conditions associated with inflammation [16–19]. In
the eye, vitamin D receptors are expressed extensively in the retina [20].
Therefore, vitamin D might prevent DR development and progression via its anti-
inflammatory and anti-angiogenic properties. There is emerging evidence that DR
is initiated and propagated by inflammation and angiogenesis [21,22]. However,
epidemiologic studies of the relationship between vitamin D and DR have been
limited, although some clinic-based case-control studies have proposed a possible
association between the 2 variables [23,24]. To our knowledge, only 1
epidemiologic study has been performed to date. A study that incorporated the
Third National Health and Nutrition Examination Survey (NHANES) data, which
was completed 20 years ago, reported an association between DR severity and the
prevalence of vitamin D deficiency. However, these findings were inconclusive
with respect to an existing relationship between DR severity and the absolute
serum vitamin D levels because the regression analysis did not show a significant
relationship. We therefore investigated the relationship between 25-hydroxyvita-
min D levels and DR in a large representative population of Korean adults.
Methods
Study population
This study used data that were acquired for the Korean National Health and
Nutrition Examination Survey (KNHANES). The KNHANES is a nation-wide,
population-based, cross-sectional study conducted by the Korean Ministry of
Health and Welfare and the Division of Chronic Disease Surveillance, Korean
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sampling design for a stratified, complex, multistage, probability cluster survey
with proportional allocations based on the National Census Registry of the non-
institutional civilian population of Korea. Details regarding the study design and
methods have been provided elsewhere [25,26]. Data from the fourth (2008–
2009) and fifth (2010–2012) KNHANES were used to estimate the association
between blood 25-hydroxyvitamin D levels and DR. For the current study, 35,056
individuals who underwent blood 25-hydroxyvitamin D level and fasting blood
glucose level evaluations were selected. Of these, 16,693 subjects aged ,40 years
and 15,180 subjects who had not been diagnosed with diabetes were excluded. Of
the 2,553 subjects with diabetes, 440 who did not undergo a fundus examination
were excluded. Finally, 2,113 participants aged $40 years were included in the
analysis (Fig. 1). The study design followed the tenets of the Declaration of
Helsinki for biomedical research. The protocols for this study were approved by
the Institutional Review Board of the Catholic University of Korea in Seoul,
Korea. All participants signed and provided written informed consent.
Data collection
A diabetes diagnosis was assigned to those with a self-reported history of
physician-based diagnosis, those who were receiving drug treatment for diabetes,
including insulin or oral hypoglycemic agents, or those with a fasting plasma
glucose level .126 mg/dL [
27]. Seven standard photographs were obtained for
both eyes after pharmacological pupil dilatation according to the Early Treatment
for Diabetic Retinopathy Study in participants with a history of diabetes, a
random blood glucose level .200 mg/dL, or suspicious diabetic DR findings in
non-mydriatic 45˚digital fundus photographs (TRC-NW6S, Topcon, Tokyo,
Japan) that were performed in all participants $40 years.
Details of the DR severity scoring method have been reported previously [28].
Briefly, DR was identified if any characteristic lesion as defined by the Early
Treatment Diabetic Retinopathy Study severity scale was present; these included
microaneurysm, hemorrhage, hard exudate, cotton wool spots, intraretinal
microvascular abnormalities, venous beading, and new vessels. A DR severity
score was assigned to each eye according to a modified version of the Airlie House
Classification system [29]. The level of retinopathy was graded based on the worse
eye. We defined 4 primary outcomes for this study on the basis of the severity
scores in the worse eye. Any DR was defined as a level .14 and proliferative DR
was defined as a level .60; clinically significant macular edema (CSME) was
considered present when the macular edema was involved or within 500 mmo f
the foveal center or if focal photocoagulation scars were present in the macular
edema. Vision-threatening DR (VTDR) was defined as the presence of severe non-
proliferative DR, proliferative DR, or CSME [29]. Two different graders analyzed
the fundus photograph images; a trained ophthalmologist acted as the senior
grader and was consulted in cases of disagreement. These graders were masked to
the clinical statuses of the subjects. The survey quality was verified by the
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Training of the participating resident doctors was periodically performed by
acting staff members of the National Epidemiologic Survey Committee of the
Korean Ophthalmologic Society.
Blood samples were collected after 10–12 hours of fasting at the same day of
taking the fundus photograph. Subsequently, the fasting glucose, hemoglobin A1c,
total cholesterol, and triglyceride levels were measured using a Hitachi automatic
analyzer 7600 (Hitachi, Ltd., Tokyo, Japan). 25-hydroxyvitamin D levels were
measured using a radioimmunoassay kit (DiaSorin Inc., Stillwater, MN, USA) and
a gamma counter (1470 WIZARD; PerkinElmer, Inc., Waltham, MA, USA).
Details of the 25-hydroxyvitamin D analysis have been reported previously.
[30,31] All blood samples for analysis were properly processed, promptly
refrigerated, and transported in cold storage to the Neodin Medical Institute
(Seoul, Korea), a Korean Ministry of Health and Welfare-certified laboratory. The
interassay coefficients of variation were 2.8–6.2% for the 2008–2009 samples and
1.9–6.1% for the 2010–2012 samples. KNHANES participates in the Vitamin D
Standardization Program; therefore, the 25-hydroxyvitamin D measurements
Fig. 1. Flow diagram presenting the selection of study participants.
doi:10.1371/journal.pone.0115199.g001
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Standards and Technology-Ghent University reference procedure [32].
Blood pressure was measured with a sphygmomanometer with the patient in a
seated position. After collecting 3 measurements at 5-minute intervals, we used
the average of the second and third measurements for the analysis. The presence
of hypertension was defined as a systolic blood pressure $140 mmHg, a diastolic
blood pressure $90 mmHg, or the use of prescribed anti-hypertensive
medication.
We collected demographic information during health interviews. We
performed height and weight measurements while the participants wore light
clothes without shoes. We calculated the body mass index as follows: weight (kg)/
height (m)
2. Age was stratified into 10-year intervals. The smoking status was self-
reported, and the subjects were classified as current smokers, past-smokers, and
never smokers. Alcohol use was self-reported, and the participants were grouped
as ever drinkers or never drinkers. Data regarding the current sunlight exposure
duration were obtained by selecting 1 of 2 options: ,5 hours or .5 hours per
day.
Statistical analysis
The statistical analysis was performed using SPSS (ver. 18.0; SPSS, Inc., Chicago,
IL, USA) to account for the complex sampling design. Strata, sampling units, and
sampling weights were used to obtain unbiased point estimates and linearized
standard errors. The participants’ characteristics were described using means and
standard errors for continuous variables and percentages and standard errors for
categorical variables according to the presence of diabetes and DR. The analysis of
variance or chi-square test was used to compare the demographic characteristics.
To evaluate the effect of the blood 25-hydroxyvitamin D levels on the DR
prevalence, the blood 25-hydroxyvitamin D levels were categorized into quintiles
[33]. Simple and multiple logistic regression analyses were used to examine the
association between the blood 25-hydroxyvitamin D level and DR. After
calculating the sex and age-adjusted odds ratios (OR; Model 1), we adjusted for
age, sex, and other confounders, including the diabetes duration, hemoglobin A1c
level, and hypertension, which have been established as independent risk factors in
previous studies (Model 2) [2,3]. For trend analysis, we evaluated change of ORs
by increase of vitamin quintiles using quintiles as continuous variable. All logistic
regression analysis variables were examined for multicollinearity, and only
variables with a variance inflation factor ,10 were used. P values were 2-tailed,
and ,0.05 was considered to indicate statistical significance.
Results
Diabetes was diagnosed in 2,553 (13.9%) of the 18,363 eligible subjects aged $40
years who underwent blood 25-hydroxyvitamin D and fasting glucose level
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Diabetic Retinopathy Study were obtained for 2,113 of the diabetic subjects
(82.7%). Therefore, 2,113 subjects were included in the current study analysis.
The demographic characteristics of the 18,363 enrolled subjects are summarized
in Table 1 according to their diabetes and DR statuses. Subjects with DR were
more likely to have a higher systolic blood pressure (P50.022), higher fasting
glucose level (P,0.001), higher hemoglobin A1c level (P,0.001), and longer
diabetes duration (P,0.001), compared to those without DR.
The demographic and clinical characteristics according to the quintile blood
25-hydroxyvitamin D categories are presented in Table 2. As the blood 25-
hydroxyvitamin D level increased, the participants were more likely to be male (P
for trend ,0.001), older (P for trend 50.016), smokers (P for trend 50.002), and
to have a lower body mass index (P for trend 50.001), lower fasting glucose level
(P,0.001), lower hemoglobin A1c level (P,0.001), and longer sun exposure
duration (P,0.001).
The blood 25-hydroxyvitamin D levels in men and women according to
categories such as age, DR, and sun exposure duration are presented in Table 3.
The blood 25-hydroxyvitamin D levels were 19.2 ng/mL (95% confidence interval
[CI], 18.7–19.8) in men and 17.9 ng/mL (95% CI, 17.2–18.6) in women
(P,0.001). In women, the mean blood 25-hydroxyvitamin D levels were
significantly higher in older subjects than in younger subjects (P,0.001); no
corresponding significant difference was observed among the men (P50.371). In
men, participants with diabetes had lower blood 25-hydroxyvitamin D levels
(P50.006); no corresponding significant difference was observed in women
(P50.321). For both sexes, the mean blood 25-hydroxyvitamin D levels were
significantly higher in those receiving .5 hours of sunlight exposure per day than
in those receiving ,5 hours per day (P,0.001). There were no significant
differences in the blood 25-hydroxyvitamin D levels between smokers and non-
smokers of either sex.
The DR prevalence rates according to the blood 25-hydroxyvitamin D quintiles
are shown in Fig. 2. As the blood 25-hydroxyvitamin D level increased, the
prevalence of any DR decreased from 19.3% in the first quintile to 14.8% in the
fifth quintile, although this difference was not statistically significant (P for trend
50.446). Additionally, the prevalence rates of proliferative DR and VTDR
decreased from 3.8% to 1.9% and from 6.0% to 3.7%, respectively, in accordance
with an increase in the blood 25-hydroxyvitamin D level, although this difference
was not statistically significant (P for trend 50.404 and 0.697, respectively).
Fig. 3
shows 25 hydroxyvitamin D levels according to the severity of DR and sex.
Table 4 lists the odds ratio (ORs) for the association of DR with the blood 25-
hydroxyvitamin D levels. Overall, there were no significant associations between
any DR, proliferative DR, CSME, and VTDR and the blood 25-hydroxyvitamin D
quintiles after adjusting for potential covariates such as age, sex, diabetes duration,
hemoglobin A1c levels, and hypertension. The adjusted OR for any DR,
proliferative DR, CSME, and VTDR were 0.66 (95% CI, 0.38–1.13), 0.52 (95% CI,
0.16–1.74), 1.22 (95% CI, 0.40–3.72), and 0.64 (95% CI, 0.25–1.59), respectively,
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those in the lowest quintile.
The DR prevalence rates among men and women according to the blood 25-
hydroxyvitamin D quintile are shown in Table 5. In men, the prevalence of any
DR significantly decreased from 20.2% to 9.5% as the blood 25-hydroxyvitamin D
level increased (P for trend 50.044). In addition, the prevalence of proliferative
DR correlated inversely with increasing blood 25-hydroxyvitamin D levels (P for
trend 50.199). In women, however, no significant relationship was found
between the DR prevalence and the 25-hydroxyvitamin D level.
Table 5 also shows the adjusted OR for DR in both men and women. In men,
the adjusted OR for any DR and proliferative DR after adjusting for potential
confounders were 0.37 (95% CI, 0.18–0.76; P for trend 50.004) and 0.15 (95% CI,
0.03–0.83; P for trend 50.043), respectively, among participants in the highest 25-
hydroxyvitamin D quintile relative to those in the lowest quintile. In women,
however, we found no significant association between the blood 25-hydro-
xyvitamin D level and the DR prevalence. Table 6 shows the prevalence of DR in
subjects with or without vitamin D deficiency (25-hydroxyvitamin D ,20 ng/
mL). Prevalence of proliferative DR was significantly higher in those with vitamin
D deficiency than in those without vitamin D deficiency (P50.002).
Table 1. Demographic and clinical characteristics, according to diabetes status and diabetic retinopathy (DR) status, as reported in the Korean National
Health and Nutrition Examination Survey 2008–2012.
Characteristics No Diabetes Diabetes p Without DR Any DR p Participants
(n515,810) (n52,553) (n51,738) (n5375) (n518,363)
Male (%) 47.8 (0.4) 55.2 (1.1) ,.001 54.9 (1.6) 54.4 (3.4) .887 48.8 (0.3)
Age (yrs) 54.4 (0.1) 60.4 (0.3) ,.001 59.7 (0.3) 61.2 (0.6) .059 57.4 (0.1)
Body mass index (kg/m
2) 23.9 (0.0) 25.0 (0.1) ,.001 25.2 (0.1) 24.0 (0.1) ,.001 24.4 (0.1)
Systolic blood pressure (mmHg) 121.7 (0.2) 128.4 (0.4) ,.001 127.2 (0.5) 130.6 (1.3) .022 125.0 (0.2)
Diastolic blood pressure (mmHg) 78.5 (0.1) 78.0 (0.2) .059 78.1 (0.3) 75.9 (0.7) .006 78.3 (0.1)
Fasting glucose (mg/dL) 94.7 (0.1) 142.6 (1.0) ,.001 141.4 (1.5) 157.8 (3.1) ,.001 118.6 (0.5)
HbA1c (%) 5.63 (0.0) 7.33 (0.0) ,.001 7.26 (0.0) 8.05 (0.1) ,.001 6.48 (0.0)
Total cholesterol (mg/dL) 194.3 (0.3) 188.0 (1.0) ,.001 187.1 (1.4) 185.8 (2.7) .668 191.1 (0.5)
Triglyceride (mg/dL) 141.9 (1.2) 183.6 (4.6) ,.001 185.5 (7.2) 180.9 (8.2) .683 162.8 (2.4)
25-hydroxyvitamin D (ng/mL) 18.7 (0.1) 18.8 (0.2) .467 18.7 (0.2) 18.3 (0.4) .380 18.8 (0.1)
Diabetes duration (years) Non applicable Non applicable 6.9 (0.2) 11.0 (0.4) ,.001 Non applicable
Hypertension (%) 36.1 (0.5) 60.4 (1.2) ,.001 60.6 (1.7) 55.8 (3.1) .166 39.2 (0.5)
Sun exposure (.5hrs/day, %) 20.0 (07) 23.4 (1.3) .001 21.1 (1.7) 19.3 (2.5) .512 20.4 (0.7)
Smoking status ,.001 .935
Never (%) 55.0 (0.5) 47.7 (1.2) 47.5 (1.7) 48.1 (3.4) 54.1 (0.4)
Former(%) 15.1 (0.4) 19.2 (1.0) 23.2 (1.4) 23.8 (3.0) 15.7 (0.4)
Current (%) 29.9 (0.5) 33.1 (1.1) 29.3 (1.5) 28.1 (2.9) 30.3 (0.4)
Alcohol consumption (%) 85.3 (0.4) 81.3 (0.9) ,.001 81.6 (1.2) 81.9 (2.3) .902 84.8 (0.3)
Data are expressed as weighted means or weighted frequency (%) with standard errors. * p,0.05.
Gradable fundus photograph was obtained in 2,113 subjects (82.7%) of 2,553 subjects with diabetes.
doi:10.1371/journal.pone.0115199.t001
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Our study demonstrated that the risks of any DR and proliferative DR decreased
in those with high blood 25-hydroxyvitamin D levels relative to those with the
lowest blood 25-hydroxyvitamin D levels. Additionally, this association between
blood 25-hydroxyvitamin D levels and DR was only observed in men.
We found that in men, the odds of any DR were 63% lower among subjects in
the highest blood 25-hydroxyvitamin D quintile relative to those in the lowest
quintile after adjusting for age, diabetes duration, hemoglobin A1c levels, and
hypertension. Our finding contradicts that of the only previous epidemiologic
study, which examined the relationship between blood 25-hydroxyvitamin D
levels and DR. The previous study showed no significant association between the 2
variables, despite finding an association between DR severity and the prevalence of
vitamin D deficiency. One possible reason for this discrepancy is the difference in
average blood 25-hydroxyvitamin D levels between the 2 studies. The median
(interquartile range) blood 25-hydroxyvitamin D concentration in the present
study was 17.7 (13.8–22.5) ng/mL, which was lower than that reported in the U.S.
NHANES (25.8 [17.9–31.1] ng/mL). However, it is unknown that low vitamin D
levels has more strong association with DR. Ethnic factors might explain this
discrepancy. The serum vitamin D levels are reportedly lower in Asian
populations than in Caucasian populations [34]. In addition, the prevalence of
Table 2. Demographic and clinical characteristics by quintile blood 25-Hydroxyvitamin D categories among representative Korean adults aged 40 years or
older.
Characteristics Quintile blood 25-Hydroxyvitamin D level (ng/mL)
13.0,(n5425) 13.0–16.5 (n5421) 16.5–19.6 (n5423) 19.6–24.4 (n5422) 24.4. (n5422)
P for
trend
Male (%) 41.4 (3.2) 50.9 (3.3) 57.4 (3.1) 64.1 (3.1) 60.7 (3.6) ,.001
Age (yrs) 69.8 (0.7) 59.0(0.6) 59.0 (0.5) 60.9 (0.6) 61.5 (0.7) .016
Body mass index (kg/m
2) 25.4 (0.2) 25.3 (0.2) 25.3 (0.3) 24.7 (0.2) 24.2 (0.1) .001
Systolic blood pressure (mmHg) 129.3 (1.0) 127.2 (1.1) 126.3 (1.1) 128.2 (1.2) 128.5 (1.3) .383
Diastolic blood pressure (mmHg) 78.3 (0.6) 77.6 (0.7) 77.6 (0.7) 77.3 (0.6) 77.7 (0.7) .864
Fasting glucose (mg/dL) 147.6 (3.5) 144.7 (3.0) 152.7 (2.9) 139.0 (2.2) 137.3 (3.0) ,.001
HbA1c (%) 7.6 (0.1) 7.4 (0.0) 7.6 (0.1) 7.1 (0.0) 7.0 (0.0) ,.001
Total cholesterol (mg/dL) 188.2 (3.5) 190.9 (2.7) 187.0 (2.6) 185.2 (2.4) 182.6 (2.6) .274
Triglyceride (mg/dL) 220.2 (23.9) 194.4 (10.4) 182.3 (9.2) 167.5 (7.3) 155.4 (7.2) .004
Diabetes duration (years) 7.8 (0.5) 8.0 (0.5) 7.4 (0.4) 8.6 (0.5) 7.7 (0.4) .417
Hypertension (%) 65.0 (3.4) 58.9 (3.1) 54.6 (3.1) 57.2 (3.3) 63.3 (3.5) .143
Sun exposure (.5 hrs/day, %) 10.8 (2.3) 17.4 (2.5) 22.1 (3.2) 24.3 (3.0) 30.1 (3.6) ,.001
Smoking status .002
Never (%) 57.4 (3.2) 47.9 (3.1) 50.4 (3.4) 38.3 (3.0) 42.8 (3.6)
Former (%) 17.0 (2.6) 20.6 (2.6) 25.2 (2.8) 30.3 (3.0) 23.4 (2.9)
Current(%) 25.5 (2.9) 31.5 (2.9) 24.4 (3.0) 31.3 (2.9) 33.8 (3.4)
Alcohol consumption (%) 77.3 (2.6) 80.6 (2.5) 82.2 (2.4) 86.1 (2.1) 82.1 (2.3) .141
*p ,0.05.
doi:10.1371/journal.pone.0115199.t002
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2 studies. Globally, vitamin D deficiency has reportedly increased during the past
few decades [35]. Industrialization has reduced the exposure of skin to sunlight,
by which means approximately 90% of vitamin D is generated [7]. Another
possible cause of this discrepancy is the that there could be methodological
difference in vitamin D measurement, because the U.S. NHANES III was
evaluated nearly 20 years ago.
Moreover, our study found that the risk of proliferative DR decreased by 85%
in those with the highest blood 25-hydroxyvitamin D levels relative to those with
the lowest levels after adjusting for potential confounders in men. One possible
biological explanation for this finding is that vitamin D inhibits angiogenesis,
which is among the most critical characteristics of proliferative DR. Vitamin D
inhibits angiogenesis by reducing vascular endothelial growth factor expression,
reducing endothelial cell proliferation, and increasing platelet-derived growth
factor expression [6,8,16]. Moreover, vitamin D also inhibits matrix-metallo-
proteinase 9, which plays a role in DR development [36,37]. Our findings
Table 3. Gender difference of blood 25-Hydroxyvitamin D levels (ng/mL) of men and women according to age group and other variables among
representative Korean adults aged 40 years or older.
Characteristics Blood 25-Hydroxyvitamin D level (ng/mL)
Men (n51,063) P Women (n51,050) P
All subjects aged 40+ years 19.2 (0.2, 18.7–19.8) 17.9 (0.3, 17.2–18.6)
Age groups .371 ,.001
40–49 yrs 18.7 (0.7, 17.3–20.1) 15.7 (0.6, 14.4–17.0)
50–59 yrs 19.0 (0.4, 18.0–19.9) 17.0 (0.5, 15.9–18.0)
60–69 yrs 19.8 (0.4, 19.0–20.6) 19.2 (0.6, 18.0–20.5)
70+ 19.7 (0.5, 18.7–20.7) 18.6 (0.5, 17.5–19.8)
Diabetic retinopathy .006 .321
None 19.5 (0.3, 18.9–20.2) 17.7 (0.3, 17.0–18.5)
Diabetic retinopathy 18.0 (0.4, 17.0–18.9) 18.6 (0.8, 17.1–20.2)
Hypertension .416 .833
Non-hypertension 19.0 (0.3, 18.2–19.8) 17.9 (0.4, 16.9–18.8)
Hypertension 19.4 (0.4, 18.7–20.2) 18.0 (0.4, 17.1–18.9)
Sun exposure .001 .001
,5 hrs/day 18.7 (0.3, 18.1–19.3) 17.5 (0.3, 16.8–18.3)
. 5 hrs/day 20.9 (0.6, 19.7–22.1) 19.8 (0.6, 18.6–21.1)
Smoking status .823 .105
Never 19.2 (0.6, 18.0–20.3) 18.0 (0.3, 17.3–18.7)
Former 19.4 (0.4, 18.5–20.3) 15.8 (0.9, 13.9–17.7)
Current 19.1 (0.4, 18.2–19.9) 17.9 (0.9, 16.1–19.7)
Alcohol consumption .768 .711
Never 19.0 (0.8, 17.3–20.6) 18.1 (0.5, 17.0–19.2)
Ever 19.2 (0.3, 18.6–19.8) 17.8 (0.4, 17.0–18.6)
Blood 25-hydroxyvitamin D levels were expressed as weighted estimates [%] (standard errors [%], 95% confidence intervals).
doi:10.1371/journal.pone.0115199.t003
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in diabetic patients to evaluate any possible effect of vitamin D on DR
development and progression.
The present study found a sex-related difference in the association between
blood 25-hydroxyvitamin D levels and DR. Although men with high blood 25-
hydroxyvitamin D levels had 63% and 85% lower risks of any DR and
proliferative DR, respectively, relative to those with the lowest levels after
adjusting for potential confounders, similar associations were not observed in
women. Moreover, a sex-related effect modification was observed. The directions
of the OR for any DR and proliferative DR in women (OR51.58 and 1.99,
respectively) were opposite those in men (OR50.37 and 0.15, respectively), which
would explain the lack of an overall association (Table 4). Our findings suggest
that hypovitaminosis D might be a significant risk factor for any DR and
proliferative DR in men but not in women. The lack of an inverse correlation
between the vitamin D status and DR in women is interesting, particularly after
accounting for the lower levels of vitamin D levels in women relative to those in
men. A study reported gender-specific association of vitamin D receptor
polymorphism which has significant effect on diabetes [38]. It is unclear why 25-
hydroxyvitamin D is associated with any DR and proliferative DR in men but not
in women. The variable threshold effect between the sexes might provide an
Fig. 2. Prevalence of any diabetic retinopathy (DR), proliferative DR, clinical significant macular edema
(CSME), and vision threatening DR (VTDR) according to the blood 25-hydroxyvitamin D level quintiles
in a representative Korean population.
doi:10.1371/journal.pone.0115199.g002
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decreased sensitivity to vitamin D. However, this is purely speculative. Further
studies are needed to identify the factors responsible for this difference and
especially to elucidate the exact sex-related biologic mechanisms. Given the data
currently in this study, any future clinical trials need to focus on men, and further
observation data exploration would be useful to help determine which findings
are real between those associated with men or those with women.
The major strengths of the present study are the relatively large number of
participants with diabetes (n52,553) and the study design that incorporated
systemically stratified, multistage, clustered random sampling methods. Another
strength is the rigorous quality control regarding ophthalmic fundus examina-
tions and blood 25-hydroxyvitamin D measurements in KNHANES. Finally, DR
was evaluated using 7 standard photographs obtained under pharmacological
dilatation. Our study also has several limitations. First, we could not adjust for
seasonal variations in the 25-hydroxyvitamin D levels because KNHANES did not
include information about the examination dates. Although a recent study
showed that Asian populations displayed no significant seasonal vitamin D status
variations [34], effect of seasonal variation in vitamin D may affect in absence of a
consistent trend between the quintiles. Second limitation is that our study
Fig. 3. 25-hydroxyvitamin D levels according to the severity of diabetic retinopathy (DR) including any
DR, proliferative DR, clinical significant macular edema (CSME), and vision threatening DR (VTDR) in a
representative Korean population.
doi:10.1371/journal.pone.0115199.g003
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causality. Third, multiple comparisons were done, because gender was found to be
effect modifier. Thus, the results stratified by gender were presented separately.
We declare that the findings of an association between retinopathy and vitamin D
in men only is at best hypothesis-generating. Finally, as dietary intervention of
vitamin D was not considered in the present study, 25-hydroxyvitamin D2 and
25-hydroxyvitamin D3 may not have equivalent physiological actions, and natural
(mainly via sunlight) and dietary sources differ in being predominantly 25-
hydroxyvitamin D2 or 25-hydroxyvitamin D3.
In conclusion, the present study provides the population-based epidemiologic
finding of an inverse relationship between the absolute blood 25-hydroxyvitamin
D levels and DR in a representative Korean population. The blood 25-
Table 4. Prevalence and adjusted odds ratio of any diabetic retinopathy (DR), Proliferative DR (PDR), Clinically significant macular edema (CSME), Vision
Threshold DR (VTDR), stratified according to quintile categories of blood 25-hydroxyvitamin D among representative Korean adults aged 40 years or older.
Quintile blood 25-Hydroxyvitamin D level (ng/mL)
13.0,(n5425) 13.0–16.5 (n5421) 16.5–19.6 (n5423) 19.6–24.4 (n5422) 24.4. (n5422)
P for
trend
Any DR
Prevalence 19.3 (2.5, 14.8–24.8) 19.5 (2.9, 14.4–
25.8)
21.2 (2.4, 16.8–
26.2)
21.0 (2.8, 16.0–
26.2)
14.8 (2.3, 10.8–
20.0)
.446
Unweighted number 87 64 90 83 60
OR
Model 1 1.0 (reference) 1.01 (0.61–1.68) 1.12 (0.73–1.73) 1.08 (0.67–1.74) 0.70 (0.42–1.16) .325
Model 2 1.0 (reference) 1.02 (0.60–1.73) 0.96 (0.58–1.59) 0.95 (0.58–1.69) 0.66 (0.38–1.13) .189
PDR
Prevalence 3.8 (1.3, 1.9–7.5) 2.5 (0.9, 1.2–4.9) 3.8 (1.0, 2.2–6.4) 2.1 (0.6, 1.1–3.8) 1.9 (0.7, 0.9–3.8) .404
Unweighted number 18 10 17 15 12
OR
Model 1 1.0 (reference) 0.66 (0.23–1.85) 1.02 (0.39–2.67) 0.54 (0.19–1.55) 0.48 (0.17–1.29) .204
Model 2 1.0 (reference) 0.63 (0.18–2.13) 0.92 (0.29–2.92) 0.48 (0.14–1.60) 0.52 (0.16–1.74) .280
CSME
Prevalence 1.8 (0.7, 0.8–3.7) 0.2 (0.2, 0.0–1.7) 2.0 (0.8, 0.8–4.5) 1.4 (0.6, 0.6–3.3) 1.6 (0.7, 0.7–3.7) .312
Unweighted number 8 1 8 6 8
OR
Model 1 1.0 (reference) 0.13 (0.01–1.09) 1.12 (0.36–3.52) 0.81 (0.25–2.58) 0.94 (0.32–2.70) .638
Model 2 1.0 (reference) 0.13 (0.01–1.15) 1.04 (0.32–3.41) 0.89 (0.25–3.16) 1.22 (0.40–3.72) .344
VTDR
Prevalence 6.0 (1.6, 3.6–10.0) 4.2 (1.1, 2.5–7.0) 5.3 (1.2, 3.4–8.2) 5.4 (1.6, 3.0–9.5) 3.7 (1.0, 2.1–6.3) .697
Unweighted number 26 18 26 25 19
OR
Model 1 1.0 (reference) 0.68 (0.31–1.51) 0.89 (0.42–1.90) 0.90 (0.38–2.14) 0.60 (0.27–1.33) .460
Model 2 1.0 (reference) 0.64 (0.25–1.64) 0.69 (0.28–1.27) 0.85 (0.31–2.37) 0.64 (0.25–1.59) .570
Prevalence was expressed as weighted estimates [%] (standard errors [%], 95% confidence intervals).
Model 1: adjusted for sex and age. Model 2: adjusted for sex, age, diabetes duration, hemoglobin A1c, and hypertension. * p,0.05.
doi:10.1371/journal.pone.0115199.t004
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PLOS ONE | DOI:10.1371/journal.pone.0115199 December 8, 2014 12 / 17Table 5. Gender difference of prevalence and adjusted odds ratio of any diabetic retinopathy (DR), Proliferative DR (PDR), Clinically significant macular
edema (CSME), Vision Threshold DR (VTDR), stratified according to quintile categories of blood 25-hydroxyvitamin D among representative Korean adults
aged 40 years or older.
Quintile blood 25-Hydroxyvitamin D level (ng/mL)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
P for
trend
Men
Range 14.1,(n5212) 14.1–17.4 (n5214) 17.4–20.5 (n5213) 20.5–25.1 (n5212) 25.1. (n5212)
Any DR
Prevalence 20.2 (3.7, 13.8–28.5) 24.5 (4.4, 17.0–
34.0)
20.2 (3.9, 13.6–
28.9)
19.2 (3.3, 13.4–
26.6)
9.5 (2.2, 6.0–14.9) .044*
Unweighted number 45 43 37 45 25
OR
Model 1 1.0 (reference) 1.28 (0.67–2.45) 0.97 (0.52–1.82) 0.91 (0.49–1.69) 0.40 (0.20–0.79)* .013*
Model 2 1.0 (reference) 1.29 (0.62–2.66) 0.75 (0.38–1.50) 0.67 (0.33–1.39) 0.37 (0.18–0.76)* .004*
PDR
Prevalence 4.4 (2.1, 1.7–11.1) 2.9 (1.5, 1.1–7.7) 2.9 (1.4, 1.1–7.3) 1.2 (0.7, 0.4–3.4) 0.8 (0.5, 0.2–3.1) .199
Unweighted number 10 5 7 4 2
OR
Model 1 1.0 (reference) 0.63 (0.15–2.66) 0.61 (0.15–2.49) 0.25 (0.06–1.04) 0.15 (0.02–0.88)* .021*
Model 2 1.0 (reference) 0.41 (0.08–2.02) 0.50 (0.10–2.33) 0.21 (0.04–0.95)* 0.15 (0.03–0.83)* .043*
CSME
Prevalence 1.2 (0.7, 0.4–3.6) 0.6 (0.6, 0.1–4.1) 1.9 (1.2, 0.5–6.5) 1.7 (1.0, 0.6–5.0) 1.4 (0.9, 0.4–4.9) .817
Unweighted number 4 1 3 4 3
OR
Model 1 1.0 (reference) 0.50 (0.05–4.77) 1.56 (0.27–8.93) 1.44 (0.29–7.15) 1.19 (0.21–6.49) .516
Model 2 1.0 (reference) 0.84 (0.08–8.57) 2.04 (0.30–13.48) 2.55 (0.47–13.76) 3.19 (0.56–17.97) .084
VTDR
Prevalence 6.9 (2.4, 3.4–13.5) 3.2 (1.5, 1.2–7.8) 7.2 (2.6, 3.5–14.3) 2.9 (1.1, 1.3–6.0) 2.2 (1.1, 0.9–5.5) .118
Unweighted number 15 8 12 7 5
OR
Model 1 1.0 (reference) 0.43 (0.13–1.46) 1.04 (0.35–3.03) 0.39 (0.13–1.15) 0.29 (0.08–0.99)* .073
Model 2 1.0 (reference) 0.28 (0.07–1.06) 0.76 (0.22–2.52) 0.30 (0.08–1.05) 0.30 (0.08–1.08) .101
Women
Range 12.1,(n5210) 12.1–15.5 (n5212) 15.5–18.6 (n5208) 18.6–23.5 (n5211) 23.5. (n5209)
Any DR
Prevalence 18.0 (3.3, 12.4–25.5) 16.4 (3.4, 10.8–
24.2)
22.2 (3.8, 15.7–
30.5)
19.3 (4.0, 12.7–
28.4)
21.8 (4.2, 14.7–
31.1)
.772
Unweighted number 39 31 46 33 40
OR
Model 1 1.0 (reference) 0.90 (0.45–1.77) 1.29 (0.69–2.42) 1.08 (0.55–2.11) 1.21 (0.62–2.37) .443
Model 2 1.0 (reference) 1.01 (0.47–2.19) 1.43 (0.70–2.89) 1.17 (0.56–2.44) 1.58 (0.78–320) .177
PDR
Prevalence 2.8 (1.1, 1.3–6.0) 2.5 (1.3, 0.9–6.7) 4.9 (1.6, 2.5–9.1) 2.3 (1.1, 0.9–5.6) 3.8 (1.4, 1.9–7.6) .603
Unweighted number 8 4 12 5 12
OR
Model 1 1.0 (reference) 0.88 (0.24–3.24) 1.77 (0.61–5.11) 0.80 (0.23–2.77) 1.38 (0.46–4.14) .625
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proliferative DR in men but not in women. It could be speculated that 25-
hydroxyvitamin D may exert a inhibitory effect on both DR development and
Table 5. Cont.
Quintile blood 25-Hydroxyvitamin D level (ng/mL)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
P for
trend
Model 2 1.0 (reference) 0.82 (0.18–3.59) 2.00 (0.62–6.42) 0.78 (0.22–2.70) 1.99 (0.68–5.83) .279
CSME
Prevalence 2.6 (1.3, 1.0–6.8) 0.5 (0.5, 0.1–3.3) 1.6 (1.2, 0.4–6.5) 0.6 (0.6, 0.1–3.7) 2.3 (1.2, 0.8–6.4) .335
Unweighted number 4 1 4 1 6
OR
Model 1 1.0 (reference) 0.17 (0.01–1.61) 0.62 (0.10–3.57) 0.21 (0.02–1.85) 0.96 (0.22–4.13) .930
Model 2 1.0 (reference) 0.18 (0.20–1.76) 0.39 (0.07–2.12) 0.16 (0.01–1.36) 0.91 (0.21–3.95) .786
VTDR
Prevalence 4.8 (1.6, 2.5–9.1) 5.2 (1.8, 2.6–10.1) 6.9 (2.0, 3.9–12.0) 3.4 (1.3, 1.6–7.2) 6.8 (1.9, 3.9–11.6) .557
Unweighted number 11 10 17 7 17
OR
Model 1 1.0 (reference) 1.08 (0.40–2.92) 1.48 (0.58–3.73) 0.70 (0.24–2.02) 1.46 (0.60–3.50) .667
Model 2 1.0 (reference) 1.09 (0.36–3.34) 1.47 (0.54–3.98) 0.55 (0.17–1.83) 1.97 (0.79–4.90) .421
Prevalence was expressed as weighted estimates [%] (standard errors [%], 95% confidence intervals).
Model 1: adjusted for sex and age. Model 2: adjusted for age, diabetes duration, hemoglobin A1c, and hypertension. * p,0.05.
doi:10.1371/journal.pone.0115199.t005
Table 6. Prevalence of any diabetic retinopathy (DR), Proliferative DR (PDR), Clinically significant macular edema (CSME), and Vision Threshold DR
(VTDR) in subjects with or without vitamin D deficiency (25-hydroxyvitamin D,20 ng/mL).
Prevalence (%) Vitamin D deficiency No Vitamin D deficiency p
Both
Any DR 19.7 (1.4) 18.0 (2.0) .494
PDR 3.3 (0.6) 1.9 (0.5) .073
CSME 1.3 (0.4) 1.5 (0.5) .698
VTDR 5.1 (0.7) 4.5 (1.0) .638
Men
Any DR 21.0 (2.4) 16.1 (2.3) .128
PDR 3.6 (1.0) 0.9 (0.4) .002*
CSME 1.3 (0.5) 1.4 (0.6) .855
VTDR 5.0 (1.2) 3.7 (1.2) .441
Women
Any DR 18.3 (1.8) 21.2 (3.2) .419
PDR 3.0 (0.7) 3.7 (1.0) .586
CSME 1.4 (0.5) 1.7 (0.8) .675
VTDR 5.1 (0.9) 5.8 (1.3) .644
Data are expressed as weighted means or weighted frequency (%) with standard errors. * p,0.05.
doi:10.1371/journal.pone.0115199.t006
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PLOS ONE | DOI:10.1371/journal.pone.0115199 December 8, 2014 14 / 17progression via its anti-angiogenic and anti-inflammatory actions. Considering
that the prevalence of vitamin D deficiency has increased worldwide in the past
few decades, further studies including longitudinal and interventional studies are
warranted.
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